跳至主要内容
临床试验/CTRI/2025/02/081209
CTRI/2025/02/081209尚未招募2/3 期

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF LANGALI GUTIKA AND DHATURADYA TAILA IN THE MANAGEMENT OF VATARAKTA

Pandit Khushilal Sharma govt autonomous ayurveda college and institute Bhopal mp1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年3月5日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
It is expected that at the end of study we would be able to demonstrate the efficacy of Langali Gutika and Dhaturadya Taila in the management of Vatarakta

研究概览

简要总结

Langali and Dhatura are considered in the upavishas,which cure many illnesses but may prove fatal on misuse. Langali is known for its high Colchicine content to be used in gout.

Dhatura is well known for its insecticidal, herbicidal, antifungal, antibacterial, anticancer, anti inflammatory and anti-rheumatoid activity.

Nowadays human beings are vulnerable to many disorders due to their altered lifestyle and food habits. Occurrence of Vatarakta is one of the outcomes of these modifications. In Ayurveda texts vata is the most significent among Tridoshas, and life of living beings absolutely depend on *rakta dhatu.*Vatarakta is a condition in which aggravated vata (due to mithya ahar-vihar) is obstructed in its path by aggravated rakta and obstructed vata once again vitiates rakta producing the disease which is characterized mainly by features like daha(Burning), toda(Pricking pain), Sandhi shool(Pain) and Sandhi sotha(Swelling) of affected joint along with discolouration of the surrounding skin.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients with classical sign & symptoms of Vatarakta and Uric acid level more than 7mg/dl for male and 6mg/dl for female.
  • 2.Patients between the ages of 20 years to 60 years.

排除标准

  • Age below 20 years and above 60 years.
  • Patient associated with any other systemic disease e.g., Diabetes, Hypertension, Severe cardiac disease etc.
  • Pregnancy and lactating mother.
  • Patient without written consent form.
  • Female patient with PCOD and heavy Bleeding in Menses.
  • Patient presenting with tophi, cellulitis, renal and liver disorder, bone deformities, rheumatoid arthritis and Osteoarthritis.

结局指标

主要结局

It is expected that at the end of study we would be able to demonstrate the efficacy of Langali Gutika and Dhaturadya Taila in the management of Vatarakta

时间窗: NIL

次要结局

  • At the end of study we would be able to demonstrate the efficacy of Langali Gutika And Dhaturadya Taila in the management of Vatarakta(Nil)

研究者

发起方
Pandit Khushilal Sharma govt autonomous ayurveda college and institute Bhopal mp
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Jagrati Ahirwar

Pt. Khushilal Sharma Govt. (Auto.) Ayurveda College and Institute Bhopal mp.

研究点 (1)

Loading locations...

相似试验